Pramiconazole

Drug Profile

Pramiconazole

Alternative Names: Azoline; R 126638

Latest Information Update: 25 Mar 2010

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator Johnson & Johnson Pharmaceutical Research & Development
  • Developer Stiefel Laboratories
  • Class Antifungals; Imidazoles; Triazoles
  • Mechanism of Action 14-alpha demethylase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Onychomycosis; Pityriasis versicolor; Tinea corporis; Tinea cruris

Most Recent Events

  • 22 Jul 2009 Stiefel Laboratories has been acquired by GlaxoSmithKline
  • 05 Feb 2008 Efficacy and adverse events data from a Phase-II trial in Pityriasis versicolor presented at the 66th Annual Meeting of the American Academy of Dermatology (AAD-2008)
  • 15 Feb 2007 Preclinical trials in Onychomycosis in Europe (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top